Loading...
•
Dec 31, 2023
Thermo Fisher Q4 2023 Earnings Report
Thermo Fisher Scientific reported fourth quarter results, navigating challenging macroeconomic conditions and delivering differentiated performance.
Key Takeaways
Thermo Fisher Scientific's fourth-quarter revenue reached $10.89 billion, a 5% decrease compared to the previous year, with a core organic revenue decline of 4%. Despite the revenue dip, the company's GAAP diluted EPS rose to $4.20, and adjusted EPS increased to $5.67, both marking a 5% increase year-over-year, driven by operating margin expansion.
Fourth quarter revenue was $10.89 billion, 5% lower versus the same quarter last year.
Core organic revenue growth declined 4%.
Fourth quarter GAAP diluted EPS was $4.20, 5% higher versus the same quarter last year, driven by 70 basis points of operating margin expansion.
Fourth quarter adjusted EPS was $5.67, 5% higher versus the same quarter last year, driven by 100 basis points of adjusted operating margin expansion.
Revenue by Segment
Forward Guidance
Thermo Fisher is initiating a guidance range for full year 2024 with revenue of $42.1 billion to $43.3 billion and adjusted EPS of $20.95 to $22.00.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...